According to a recent LinkedIn post from Medivis, the company participated in two practical clinics at the American Association of Neurological Surgeons Annual Scientific Meeting, centered on the use of virtual reality and artificial intelligence in cranial and spinal neurosurgery. The post indicates that Medivis’ augmented reality technology was featured in lectures by Dr. Randy D’Amico and Dr. Michael E. Ivan, suggesting growing clinical interest in AR-guided surgical approaches.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that augmented reality integration in surgery is increasingly viewed as an implementation challenge rather than a speculative concept, which may signal accelerating adoption curves for enabling technologies. For investors, this visibility at a major neurosurgical conference could point to strengthening validation from key opinion leaders, potentially supporting Medivis’ positioning in the surgical navigation and digital surgery markets.
The post also implies that Medivis aims to play a leading role in defining how AR is incorporated into operating room workflows, which may translate into opportunities for deeper hospital partnerships and recurring software or platform revenue models over time. If the momentum described in the post continues, the company could benefit from network effects as more surgeons train on and advocate for AR-guided techniques in real-world practice.

